Concordance of Key Actionable Genomic Alterations as Assessed in Tumor Tissue and Plasma in Non Small Cell Lung Cancer

NCT02762877 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 140

Last updated 2020-11-17

Study results available
· View outcomes & findings →

Summary

A study to determine the concordance of key actionable genomic alterations as assessed in tumor tissue and plasma from patients with non small cell lung carcinoma (NSCLC)

Conditions

  • Non Small Cell Lung Carcinoma

Sponsors & Collaborators

  • Genomic Health®, Inc.

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-04-30
Primary Completion
2018-07-01
Completion
2019-06-19

Countries

  • United States
  • Chile
  • France
  • Ireland
  • Japan
  • Spain
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02762877 on ClinicalTrials.gov